SCYNEXIS Announces Presentations at 2020 IDSOG Virtual Annual Meeting Highlighting Ibrexafungerp's Potential for the Treatment of Vulvovaginal Candidiasis
Stock Information for SCYNEXIS Inc.
Loading
Please wait while we load your information from QuoteMedia.